BBOTVSGTBP• 28 Days (Normalized)
BBOT vs GTBP (BridgeBio Oncology Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
+2431.12%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-2487.8 pts
GTBP outperforming by 2487.80 percentage points
BBOTGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BBOT Price | BBOT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.68% | $6.10 | +2431.12% | -2487.80% |
| Sep 30, 2026 | $4.10 | -54.34% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.35% | $6.88 | +2752.70% | -2809.05% |
| Sep 28, 2026 | $3.81 | -57.57% | $6.80 | +2721.58% | -2779.15% |
| Sep 25, 2026 | $3.95 | -56.01% | $6.89 | +2758.92% | -2814.93% |
| Sep 24, 2026 | $3.99 | -55.57% | $6.83 | +2734.02% | -2789.59% |
| Sep 23, 2026 | $4.16 | -53.67% | $7.10 | +2846.06% | -2899.73% |
| Sep 22, 2026 | $4.66 | -48.11% | $- | - | |
| Sep 21, 2026 | $4.66 | -48.11% | $7.18 | +2879.25% | -2927.36% |
| Sep 18, 2026 | $4.77 | -46.88% | $7.16 | +2870.95% | -2917.83% |
| Sep 17, 2026 | $4.89 | -45.55% | $7.49 | +3007.88% | -3053.43% |
| Sep 16, 2026 | $4.76 | -46.99% | $7.81 | +3140.66% | -3187.65% |
| Sep 15, 2026 | $4.88 | -45.66% | $9.00 | +3634.44% | -3680.10% |
| Sep 14, 2026 | $5.05 | -43.76% | $11.63 | +4725.73% | -4769.49% |
| Sep 11, 2026 | $4.95 | -44.88% | $8.61 | +3472.61% | -3517.49% |
Page 1 of 2